{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:57:34Z","timestamp":1791176254478,"version":"4.1.0"},"update-to":[{"DOI":"10.1016\/j.ijpharm.2012.05.025","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"record-id":"17563"}],"reference-count":33,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["EY017045"],"award-info":[{"award-number":["EY017045"]}]},{"name":"NIH","award":["EY018940"],"award-info":[{"award-number":["EY018940"]}]},{"name":"NIH","award":["EY017533"],"award-info":[{"award-number":["EY017533"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.ijpharm.2012.05.025","type":"journal-article","created":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T17:45:12Z","timestamp":1337795112000},"page":"140-147","source":"Crossref","is-referenced-by-count":33,"title":["RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide"],"prefix":"10.1016","volume":"434","author":[{"given":"Rajendra S.","family":"Kadam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry F.","family":"Edelhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday B.","family":"Kompella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.05.025_bib0005","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1167\/iovs.05-0531","article-title":"Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage","volume":"47","author":"Amrite","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/jop.2008.0090","article-title":"Fluocinolone inhibits VEGF expression via glucocorticoid receptor in human retinal pigment epithelial (ARPE-19) cells and TNF-alpha-induced angiogenesis in chick chorioallantoic membrane (CAM)","volume":"25","author":"Ayalasomayajula","year":"2009","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1167\/iovs.07-0214","article-title":"Effect of eye pigmentation on transscleral drug delivery","volume":"49","author":"Cheruvu","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0020","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s11095-008-9757-2","article-title":"Effect of diabetes on transscleral delivery of celecoxib","volume":"26","author":"Cheruvu","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0025","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/00006982-200507000-00002","article-title":"Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes","volume":"25","author":"Chin","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0030","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/archopht.1989.01070010270035","article-title":"A new model of experimental choroidal neovascularization in the rat","volume":"107","author":"Dobi","year":"1989","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0035","doi-asserted-by":"crossref","first-page":"e18481","DOI":"10.1371\/journal.pone.0018481","article-title":"Influence of Dll4 via HIF-1alpha-VEGF signaling on the angiogenesis of choroidal neovascularization under hypoxic conditions","volume":"6","author":"Dong","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0040","first-page":"385","article-title":"Foveolar choroidal blood flow in age-related macular degeneration","volume":"39","author":"Grunwald","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0045","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1167\/iovs.04-1050","article-title":"Reduced foveolar choroidal blood flow in eyes with increasing AMD severity","volume":"46","author":"Grunwald","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0050","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0014-4835(03)00189-1","article-title":"Retinal pigment epithelium and endothelial cell interaction causes retinal pigment epithelial barrier dysfunction via a soluble VEGF-dependent mechanism","volume":"77","author":"Hartnett","year":"2003","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0055","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1056\/NEJMra0801537","article-title":"Age-related macular degeneration","volume":"358","author":"Jager","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0060","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00417-002-0547-y","article-title":"Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration","volume":"240","author":"Jonas","year":"2002","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0065","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1124\/jpet.109.161570","article-title":"Influence of lipophilicity on drug partitioning into sclera, choroid-retinal pigment epithelium, retina, trabecular meshwork, and optic nerve","volume":"332","author":"Kadam","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0070","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1167\/iovs.02-0791","article-title":"Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression","volume":"44","author":"Kompella","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0075","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4155\/tde.10.40","article-title":"Recent advances in ophthalmic drug delivery","volume":"1","author":"Kompella","year":"2010","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0080","first-page":"3158","article-title":"VEGF is major stimulator in model of choroidal neovascularization","volume":"41","author":"Kwak","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0085","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1080\/02652040600946886","article-title":"Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin","volume":"23","author":"Lecaroz","year":"2006","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0090","first-page":"13","article-title":"Vascular endothelial growth factor and ocular neovascularization","volume":"151","author":"Miller","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0095","first-page":"561","article-title":"Nanoparticles \u2013 a review","volume":"5","author":"Mohanraj","year":"2006","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0100","first-page":"353","article-title":"Age-related macular degeneration (AMD): pathogenesis and therapy","volume":"58","author":"Nowak","year":"2006","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0105","first-page":"83","article-title":"Age-related macular degeneration (AMD): etiopathogenesis and therapeutic strategies","volume":"61","author":"Nowak","year":"2007","journal-title":"Postepy. Hig. Med. Dosw. (Online)"},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0008-4182(05)80119-X","article-title":"Complications of intravitreal injection of triamcinolone acetonide","volume":"40","author":"Ozkiris","year":"2005","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1517\/17425247.1.1.99","article-title":"Periocular routes for retinal drug delivery","volume":"1","author":"Raghava","year":"2004","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0120","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0168-3659(00)00367-9","article-title":"Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation","volume":"70","author":"Redhead","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0125","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.exer.2005.08.007","article-title":"A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide","volume":"82","author":"Robinson","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0130","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1167\/iovs.08-3078","article-title":"Toxicity assessment of intravitreal triamcinolone and bevacizumab in a retinal explant mouse model using two-photon microscopy","volume":"50","author":"Schlichtenbrede","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0135","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.ophtha.2011.02.034","article-title":"Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents","volume":"118","author":"Shah","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0140","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s13346-010-0009-8","article-title":"Intravitreal poly(l-lactide) microparticles sustain retinal and choroidal delivery of TG-0054, a hydrophilic drug intended for neovascular diseases","volume":"1","author":"Shelke","year":"2011","journal-title":"Drug Deliv. Trans. Res."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0002-9440(10)64525-7","article-title":"Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization","volume":"157","author":"Spilsbury","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0150","series-title":"Ophthalmic drug Delivery Systems","article-title":"Membrane transport processes in the eye","author":"Sunkara","year":"2003"},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0155","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1124\/dmd.110.037408","article-title":"Influence of drug solubility and lipophilicity on transscleral retinal delivery of six corticosteroids","volume":"39","author":"Thakur","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0160","first-page":"1490","article-title":"Effects of triamcinolone on the expression of VEGF and PEDF in human retinal pigment epithelial and human umbilical vein endothelial cells","volume":"12","author":"Tong","year":"2006","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ijpharm.2012.05.025_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02980037","article-title":"Control of encapsulation efficiency and initial burst in polymeric microparticle systems","volume":"27","author":"Yeo","year":"2004","journal-title":"Arch. Pharm. Res."}],"updated-by":[{"DOI":"10.1016\/j.ijpharm.2012.05.025","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"record-id":"17563"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312005108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312005108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T17:34:37Z","timestamp":1556732077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312005108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":33,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0378517312005108"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.05.025","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}